Exhibit 107
Calculation of Filing Fee Tables
424(b)(5)
(Form Type)
Mirum Pharmaceuticals, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
Security Type | Security Class Title | Fee Calculation Rule(1) | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||
Fees to Be Paid | Equity | Common Stock, par value $0.0001 per share | Rule 457(o) and 457(r) | N/A | N/A | $200,000,000.00 | 0.00014760 | $29,520.00 | ||||||||
Total Offering Amounts | $200,000,000.00 | $29,520.00 | ||||||||||||||
Total Fees Previously Paid | — |
Table 2: Carry Forward Securities
Security Type | Security Class Title | Fee Calculation Rule | Amount Registered | Proposed Maximum Offering Price Per Share | Maximum Aggregate Offering Price | Fee Rate | Amount of Registration Fee | |||||||||
Carry Forward Securities | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |||||||||
Total Offering Amounts | $200,000,000.00 | $29,520.00 | ||||||||||||||
Total Fees Previously Paid | — | |||||||||||||||
Total Fee Offsets | — | |||||||||||||||
Net Fee Due | $29,520.00 |
(1) | The filing fee is calculated and is being paid pursuant to Rules 456(o) and 457(r) under the Securities Act of 1933, as amended (the “Securities Act”), based on the proposed maximum aggregate offering price. The Registrant initially deferred payment of the registration fees for its Registration Statement on Form S-3 (File No. 333-267357) filed by the Registrant with the Securities and Exchange Commission on September 9, 2022 pursuant to Rules 456(b) and 457(r) under the Securities Act. |